Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial - Aix-Marseille Université Access content directly
Journal Articles The Lancet Regional Health - Western Pacific Year : 2021

Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial

Xi-Yu Liu
  • Function : Author
Li Chen
  • Function : Author
Miao Mo
  • Function : Author
Jiong Wu
  • Function : Author
Guang-Yu Liu
  • Function : Author
Gen-Hong Di
  • Function : Author
Claire Verschraegen
Daniel Stover
  • Function : Author
Zhi-Gang Zhuang
  • Function : Author
Armando Orlandi
  • Function : Author
Ke-Jin Wu
  • Function : Author
Lei Fan

Domains

Cancer

Dates and versions

hal-03623636 , version 1 (29-03-2022)

Identifiers

Cite

Ke-Da Yu, Xi-Yu Liu, Li Chen, Miao Mo, Jiong Wu, et al.. Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial. The Lancet Regional Health - Western Pacific, 2021, 11, pp.100158. ⟨10.1016/j.lanwpc.2021.100158⟩. ⟨hal-03623636⟩

Collections

CNRS UNIV-AMU CRCM
10 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More